Lamotrigine Associated DRESS Syndrome – a Case Report

1. Sontheimer RD, Houpt KR. DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome. Arch Dermatol 1998;134:874–6.10.1001/archderm.134.7.874Search in Google Scholar

2. Phillips EJ, Chung WH, Mockenhaupt M, Roujeau J, Mallal SA. Drug hypersensitivity: pharmacogenetics and clinical syndromes. J Allergy Clin Immunol 2011;127(3 Suppl):S60–6.10.1016/j.jaci.2010.11.046Search in Google Scholar

3. Descamps V, Ben Saïd B, Sassolas B, Truchetet F, Avenel-Audran M, Girardin P, et al. Prise en charge du drug reaction with eosinophilia and systemic symptoms (DRESS). Ann Dermatol Venereol 2010;137:703–8. [In French]10.1016/j.annder.2010.04.024Search in Google Scholar

4. Buck ML. DRESS Syndrome. Pediatr Pharm 2012;18(11).Search in Google Scholar

5. Leão RN, Barreto P, Leão RP, Ribeiro JV. Nitrofurantoin: cause of DRESS syndrome. BMJ Case Rep 2013;2013.10.1136/bcr-2013-008991Search in Google Scholar

6. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007;156:1083–4.10.1111/j.1365-2133.2007.07807.xSearch in Google Scholar

7. Choudhary S, McLeod M, Torchia D, Romanelli P. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. J Clin Aesthet Dermatol 2013;6(6):31–7.Search in Google Scholar

8. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007;156:609-11.Search in Google Scholar

9. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug ypersensitivity syndrome (Drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 1996;15:250-7.10.1016/S1085-5629(96)80038-1Search in Google Scholar

10. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome. Part II. Management and therapeutics. J Am Acad Dermatol 2013;68:709-17.Search in Google Scholar

11. Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol 2010;146:1373–9.10.1001/archdermatol.2010.19820713773Search in Google Scholar

12. Descamps V, Ranger-Rogez S. DRESS syndrome. Joint Bone Spine 2014;81:15–21.10.1016/j.jbspin.2013.05.00223816504Search in Google Scholar

13. Halink DA, Marijnissen RM, Schut AA, Oude Voshaar RC. Drug reaction with eosinophilia and systemic symptoms induced by carbamazepine: DRESSed to kill. Gen Hosp Psychiatry 2011;33(4):412.e5–8.10.1016/j.genhosppsych.2011.04.01221762844Search in Google Scholar

14. Tetart F, Picard D, Janela B. Prolonged evolution of drug reaction with eosinophilia and systemic symptoms: clinical, virologic, and biological features. JAMA Dermatol 2014;150:206-7.10.1001/jamadermatol.2013.669824369386Search in Google Scholar

15. Kano Y, Hiraharas K, Sakuma K, Shiohara T. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 2006;155:301-6.10.1111/j.1365-2133.2006.07238.x16882166Search in Google Scholar

16. Tohyama M, Hashimoto K, Yasukawa M. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol 2007;157:934-40.10.1111/j.1365-2133.2007.08167.x17854362Search in Google Scholar

17. Um SJ, Lee SK, Kim YH, Kim KH, Son CH, Roh MS, et al. Clinical features of drug-induced hypersensitivity syndrome in 38 patients. J Investig Allergol Clin Immunol 2010;20:556–62.Search in Google Scholar

18. Chan JC, Chan HH, Yeung CK. Drug reaction with eosinophilia and systemic symptoms. Hong Kong J Dermatol Venereol 2012;20:163-70.Search in Google Scholar

19. Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu C, Creamer D, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 2013;169:1071-80.10.1111/bjd.1250123855313Search in Google Scholar

20. Genin E, Chen DP, Hung SI, Sekula P, Schumacher M, Chang PY, et al. HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis. Pharmacogenomics J 2014;14:281-8.10.1038/tpj.2013.4024322785Search in Google Scholar

21. Ganeva M, Gancheva T, Lazarova R, Troeva J, Baldaranov I, Vassilev I, et al. Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. Int J Dermatol 2008;47(8):853-60.10.1111/j.1365-4632.2008.03637.x18717872Search in Google Scholar

22. Choi HG, Byun J, Moon HC, Yoon JH, Yang KY, Park SC, et al. Allopurinol-induced DRESS syndrome mimicking biliary obstruction. Clin Mol Hepatol 2014;20(1):71–5.10.3350/cmh.2014.20.1.71399233324757661Search in Google Scholar

23. Brown RJ, Rother KI, Artman H, Mercurio MG, Wang R, Looney RJ, et al. Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch Dermatol 2009;145(1):63–6.10.1001/archdermatol.2008.521295458819153345Search in Google Scholar

24. Lee JH, Park HK, Heo J, Kim TO, Kim GH, Kang DH, et al. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs. J Korean Med Sci 2008;23(3):521–5.10.3346/jkms.2008.23.3.521252654018583892Search in Google Scholar

25. Taylor JL, Kulkarni MS, Behringer EC, Yusufali T, Trento A, D’Attellis NP. Minocycline-induced drug reaction with eosinophilia and Systemic symptoms syndrome: myocarditis and multiple organ failure. ICU Dir 2012;3(3):139-43.10.1177/1944451612442687Search in Google Scholar

26. Wenk KS, Pichard DC, Nasabzadeh T, Jang S, Venna SS. Vemurafenib-induced DRESS. JAMA Dermatol 2013;149:1242-3.10.1001/jamadermatol.2013.527823986488Search in Google Scholar

27. Naisbitt DJ, Farrell J, Wong G, Deptta JP, Dodd CC, Hopkins JE, et al. Characterization of drug-specific T cells in lamotrigine hypersensitivity. J Allergy Clin Immunol 2003;111:1393–403.10.1067/mai.2003.150712789244Search in Google Scholar

28. Su-Yin AN, Tai WW, Olson RK. Lamotrigine-associated reversible severe hepatitis: a case report. J Med Toxicol 2008;4(4):258–60.10.1007/BF03161210355011819031378Search in Google Scholar

29. Naveen KN, Ravindra MS, Pai VV, Rai V, Athanikar SB, Girish M. Lamotrigine induced DRESS syndrome. Indian J Pharmacol 2012;44(6):798–800.10.4103/0253-7613.103305352351323248415Search in Google Scholar

30. Božić K, Gebauer Bukurov K, Jovanović M, Vujanović Lj, Slankamenac P. Serious rash after prolonged use of lamotrigine - report of four cases. HealthMed 2011;5(2):409-12.Search in Google Scholar

31. Ginory A, Chaney-Catchpole M, Demetree JM, Mayol Sabatier LM, Nguyen M. Drug reaction with eosinophilia and systemic symptoms (DRESS) in an adolescent treated with lamotrigine. J Pediatr Pharmacol Ther 2013;18(3):236–40.10.5863/1551-6776-18.3.236377555824052787Search in Google Scholar

32. Parri N, Bernardini R, Pucci N, Novembre E, Azzari C, Vierucci A. Drug rash with eosinophilia and systemic symptoms induced by lamotrigine therapy. Int J Immunopathol Pharmacol 2007;20:643-5.10.1177/03946320070200032317880778Search in Google Scholar

33. Hussain N, Gosalakkal JA. Lamotrigine rash–a potentially life-threatening complication. Emerg Med J 2007;24:448.10.1136/emj.2006.037754265829817513556Search in Google Scholar

34. Aouam K, Ben Romdhane F, Loussaief C, Salem R, Toumi A, Belhadjali H, et al. Hypersensitivity syndrome induced by anticonvulsants: possible cross-reactivity between carbamazepine and lamotrigine. J Clin Pharmacol 2009;49:1488-91.10.1177/009127000934498519723672Search in Google Scholar

35. Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: a literature review. Am J Med 2011;124:588-97.10.1016/j.amjmed.2011.01.01721592453Search in Google Scholar

36. Prevost P, Bédry R, Lacoste D, Ezzedine K, Haramburu F, Milpied B. Hypersensitivity syndrome with olanzapine confirmed by patch tests. Eur J Dermatol 2012;22:126-7.10.1684/ejd.2011.155322157728Search in Google Scholar

37. Darlenski R, Kazandjieva J, Tsankov N. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS. Clin Dermatol 2015; In press. doi: 10.1016/j.clindermatol.2015.05.00510.1016/j.clindermatol.2015.05.00526321400Search in Google Scholar

38. Brajon D, Trechot P, Waton J, Cuny JF, Schmutz JL, Barbaud A. Suspicion of a new cross-reaction between carbamazepine and olanzapine. J Investig Allergol Clin Immunol 2014;24(1):60-1.Search in Google Scholar

39. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–45.10.1038/clpt.1981.1547249508Search in Google Scholar